SBIRT..What should I know?

Slides:



Advertisements
Similar presentations
CE REVIEW UNDERSTANDING HYPERTENSION. Hypertension is a chronic medical condition affecting more than 65 million Americans. Controlling hypertension is.
Advertisements

Substance Use Disorder Treatment Supporting the Field with Evidence and Logic.
Drugs For Treating Drug Addiction Barry Zevin MD Tom Waddell Health Center San Francisco Department of Public Health Homeless Programs Board Certified.
 William Frank Barker, LPC, MAC Diane Diver, LMSW, CAC II.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse What Do We Know? Drug Abuse.
Advancing the prevention and treatment of chronic illnesses UCLA Department of Family Medicine Psychoactive Drugs and HIV Steven Shoptaw, PhD UCLA Center.
Lincoln County School District Nurses Julie Turner RN Betsy Brooks RN Drug and Alcohol Awareness.
Commonly Abused Drugs Among College Students April 2013 P urdue U niversity C alumet C ounseling C enter Gyte Room 005 (219)
LEGAL AND ILLEGAL SUBSTANCES. LEGAL DRUGS Legal drugs are considered permissible for use, and are either prescribed by a physician (prescription medications)
Drugs for Hypertension
Mental Illness and Addiction: Changing Perspectives Presented by Terri White, MSW Commissioner Oklahoma Department of Mental Health and Substance Abuse.
New Pathways, New Connections: Tobacco and Behavioral Health Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention National Conference.
TRANSLATING VISITS INTO PATIENTS USING AMBULATORY VISIT DATA (Hypertensive patient case study) by Esther Hing, M.P.H. and Julia Holmes, Ph.D U.S. DEPARTMENT.
Taking drugs if you have ___ is BAD. Increased rates transmission Unprotected sex –Anal intercourse Group sex or multiple partners Internet partners Injection.
The National Prevention Strategy and Behavioral Health Care: Prevention Is Now RADM Peter J. Delany, Ph.D., LCSW-C Substance Abuse and Mental Health Services.
From the Monitoring the Future Study Report: The University of Michigan 2012.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Nora D. Volkow, M.D. Director National Institute on Drug Abuse Nora D. Volkow, M.D. Director National Institute on Drug Abuse Research Advances in What.
H.R Prescription drug abuse prevention and treatment Act of 2011.
 Methadone is prescribed to relieve moderate to severe pain that has not been relieved by non-narcotic pain relievers.
Pamela S. Hyde, J.D. SAMHSA Administrator American Society of Addiction Medicine 42 nd Annual Medical-Scientific Conference Washington, DC April 15, 2011.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Addictive Behaviors Chapter 12 Overview Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Prevention, Identification and Treatment of Opioid Use Disorders: A Personal Perspective Leah Bauer, MD Medical Director, Addiction Resource Center, Mid.
CHAPTER 12 SUBSTANCE-RELATED AND ADDICTIVE DISORDERS Copyright © 2014 McGraw-Hill Education. All rights reserved. No reproduction or distribution without.
1 Did You Know 42% of US high school seniors use alcohol.
60 Ferebee Enterprises International, LLC Global Female Empowerment o/ c
Substance Abuse By: Joe Gonzalez & Danielle Lyner.
The Science of Addiction. Homelessness Crime Violence Homelessness Crime Violence Neurotoxicity AIDS, Cancer Mental illness Neurotoxicity AIDS, Cancer.
Substance Use Disorders and Overdose: The Basics Public Curricula – Essential Knowledge for Families and Communities Core Component.
Module 1–1 1TIP45 Training Curriculum U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration Center for.
Tom Burns, Special Agent
Substance Exposed Newborns: Addressing Substance Use Disorder
The Highs and Lows of Relapse and Recovery in Opioid Use Disorder
screening, brief intervention and referral to treatment
Jessica E. Bates, Pharm.D. PGY-1 Pharmacy Resident
National Health Reform is Essential
THE OPIOID CRISIS Mississippi Board of Nursing
10th Annual Susan Li Conference
Medication-Assisted Therapy at Coleman Profession Services
Drugs for Hypertension
Medicinal and Recreational Drugs
Working with Adolescents: Additional Considerations
Narcotics, Stimulants, and Depressants
Addressing the Opioid Epidemic
Outpatient Alcohol/Drug Abuse Centers
Understanding the Opioid Epidemic
Narcotics, Stimulants, and Depressants
Opioids – A Pharmaceutical Perspective on Prescription Drugs
MODULE 2- EPIDEMIOLOGY OF DRUG USE IN THE AMERICAS
Opioid Addiction 1990’s-present.
CASA is a leading national addiction policy and research organization
MEDICATION ASSISTED TREATMENT for OPIATE ADDICTION
The Epidemiology of Injury and Science of Injury Prevention
Substance-Related and Addictive Disorders
Medication Assisted Treatment
Module 1: Putting Drugs of Abuse and Clients in Perspective
Addiction Why It’s YOUR Business
Medication-assisted treatment for opioid use disorder John e lopes jr
General Guidelines for Creating an Effective Poster
2017 Annual Report Snippets NSDUH, SAMHSA, USA DHHS Selected Trends
Table of Contents Why Do We Treat Hypertension? Recommendation 5
ADDICTION
Jim Messina, Ph.D., CCMHC, NCC, DCMHS-T
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Substance Use Prevention for Young Adults and Higher Education
Medications used in Treatment of Alcohol and Drug Use Disorders
Strategic Initiatives to Address Opioid Overdose & Addiction
Medically assisted treatment
Center for Behavioral Health Statistics and Quality
Presentation transcript:

SBIRT..What should I know? Michelle Bauer MD Addiction Psychiatry .Addiction Medicine Medical Director Substance Use Disorder Service VAMC

Screening,BrIef Intervention and Referral to Treatment Evidence base approach supported by SAMHSA since 2003 for use in primary care setting and some other settings. Goal is to reduce frequency and severity of alcohol use. Promote early involvement of primary care providers in prevention and treatment of substance use disorder

Substance use and related disorders are among the leading causes of preventable injuries and illnesses 21.5million americans 12 or older had substance use disorder in 2014

Where ever you go….. Medicine……..liver cirrhosis, HIV Cardiology……myocardial infarction ,arrhythmia Neurology……neuropathy, Parkinson, Korsakoff Pulmonary……small cell Ca,pulmonary edema Obstetrics…….abruptio placenta Surgery………..trauma,fractures Pediatrics……..FAS,NAS,asthma

Alcohol use disorder Most people drink with moderation . 87.6% adult over 18 reported they drank alcohol at some point in their life Lifetime prevalence Alcohol Use Disorder is 29.1% However of those 176.6 million alcohol users,an estimated 17million have alcohol use disorder 1.5million received treatment for AUD (8.9% of adult who need treatment)

Tobacco use disorder In 2014, 66.9 million Americans aged 12 or older were current users of a tobacco product. Young adults aged 18 to 25 had the highest rate of current use of a tobacco product (35%), followed by adults aged 26 or older (25.8%), and by youths aged 12 to 17 (7%). Tobacco 66.9

Cannabis use disorder Marijuana is the most-used drug after alcohol and tobacco in the United States. In 2014, about 22.2 million people ages 12 and up reported using marijuana during the past month.

Stimulant use disorder In 2014, an estimated 913.000 people ages 12 and older had a stimulant use disorder because of cocaine use. 476.000 people had a stimulant use disorder as a result of using other stimulants besides methamphetamine. In 2014, almost 569.000 people in the United States ages 12 and up reported using methamphetamine in the past month.

Opioid use disorder In 2014 an estimated 1,9 million people had an opioid use disorder related to prescription pain relievers and 586 000 had opioid use disorder related to heroin Overdose death from opioids have nearly quadruple since 1999 (increase 265% in man and 400% in women ) 28 000 people died from opioid OD in 2014 (more than 1/2 related to prescription drugs ) Approximately 3 out of 4 new heroin users abused prescription opioids before switching to heroin In 2014 an estimated1,9 millions people had an opioid use disorder related to prescription pain relievers and 586 000 had an opioid use disorder related to heroin Overdose death from opioids,have nearly quadruple since1999. Overdose involving opioids killed more than 28000 people in2014. Over half of these deaths were from prescription opioids.

Perspective High blood pressure…………75 million /410 000 Tobacco use disorder……….66.9 million /88 000 Diabetes…………………….29.1 million / 75 578 Cannabis use disorder……..22.2 million Asthma……………………….17.7 millions /3630 Alcohol use disorder………..17 million /88 000 Opioid use disorder……1.9 million +586 K /18 930+10 574

“I am right there in the room and no one even acknowledges me“

WHY ?

Same disease ..complex illness . Addiction is a brain disease

Pharmacology

Substance use Disorder Alcohol use disorder. Disulfiram 1950. Naltrexone PO and IM Acamprosate Tobacco use disorder Nicotine gum 1984. Bupropion 1997. Varenicline Opioids use disorder Methadone. Buprenorphine

Diabetes 28 different drugs…. 9 insulin ,rapid,short intermediate long acting 14 sulfonylurea-3rd generation, 4 DPP-4 inhibitor (Sitagliptin ,Alogliptin ), 3 bile sequestrates (Cholestyramine ) 1 biguanide (Metformin), 3 meglitinides(Repaglinide), 2 thiazolidinediones ,( Pioglitazone ) 2 alpha glucosidase inhibitor(Acarbose,Miglitol)

Hypertension 63 FDA approved medication 6 diuretics 3 potassium sparing diuretics 1 loop diuretic 13 beta blockers 10 ACE inhibitors 6ARB 8 calcium channel blocker 3 alpha blockers 1 alpha2 receptor agonist 4 central agonist 3 peripheral adrenergic inhibitor 2 vasodilators 2 combined alpha and beta blockers

Asthma 23 FDA approved medication . 9 corticosteroids, 5 long acting beta blockers, Cromolyn sodium, 2 leukotriene modifiers (Zabirlukast), 1 5lipoxygenase inhibitor (Zileuton ) Short acting beta 2 agonist

Patient Interview

Language is source of misunderstandings Antoine de Saint Exupery

Many physicians admit they are not confident about how to prescribe opioids safely,how to detect abuse or emerging addiction or even how to discuss these issues with their patients Nora Volkow

Whoa! way too much information!

“You should relax less..”

“You said you need to relax. Let’s talk about it “

References Substance Abuse and Mental Health Administration. www.samhsa.gov National Institute on Drug Abuse. www.drugbuse.gov SBIRT:Public health training for primary care . R.Taylor MD ,American Journal Public Health ,August 2012 ,vol 102,No 8 Neurobiologic advances from the Brain Disease model of Addiction . Nora Volkow MD,George Koob,PHD Thomas McLellanPHD:N England J Medicine 374:4,January 28 2016 The Future of Public Health Thomas Frieden MD,MPH :N England J Medicine 373;18 ,October 29 2015 Drug dependence,a chronic medical illness . Thomas McLellan ,JAMA Vol 284,No13;October 4 2016